Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$2.72B |
| 2 |
Meta Platforms (Facebook)
META
|
+$660M |
| 3 |
Micron Technology
MU
|
+$605M |
| 4 |
Mastercard
MA
|
+$497M |
| 5 |
Tesla
TSLA
|
+$495M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.33B |
| 2 |
Visa
V
|
+$1.26B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 4 |
Lam Research
LRCX
|
+$699M |
| 5 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$681M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 79.37% |
| 2 | Technology | 4.49% |
| 3 | Healthcare | 2.99% |
| 4 | Financials | 2.85% |
| 5 | Industrials | 2.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
APM
12176
DELISTED
Aptorum Group
APM
| $73.6K | ﹤0.01% |
92,420
-23,164
| -20% | -$20.9K |
2025 Q4
1 quarter
|
|
12177
Pulmonx
LUNG
$78.6M
| $73.5K | ﹤0.01% |
57,009
+11,752
| +26% | +$19.4K |
2020 Q4
21 quarters
|
|
|
FINV
12178
FinVolution Group
FINV
$685M
| $73.5K | ﹤0.01% |
15,344
-648,227
| -98% | -$3.44M |
2024 Q3
6 quarters
|
|
12179
PUT
Rackspace Technology
RXT
$1.05B
| $73.5K | ﹤0.01% |
75,000
+60,500
| +417% | +$73.5K |
2025 Q3
2 quarters
|
|
12180
CALL
Priority Technology Holdings
PRTH
$642M
| $73.2K | ﹤0.01% |
+15,500
| New | +$84.9K |
2026 Q1
0 quarters
|
|
12181
PUT
Protara Therapeutics
TARA
$160M
| $72.9K | ﹤0.01% |
+14,000
| New | +$82.9K |
2026 Q1
0 quarters
|
|
12182
PUT
LENSAR
LNSR
$82.9M
| $72.7K | ﹤0.01% |
+12,200
| New | +$133K |
2026 Q1
0 quarters
|
|
12183
CALL
Ampco-Pittsburgh
AP
$200M
| $72.6K | ﹤0.01% |
10,800
-200
| -2% | -$1.44K |
2025 Q4
1 quarter
|
|
12184
Information Services Group
III
$276M
| $72.5K | ﹤0.01% |
18,882
-93,535
| -83% | -$460K |
2023 Q3
10 quarters
|
|
12185
CALL
Gossamer Bio
GOSS
$65.5M
| $72.3K | ﹤0.01% |
2,751
-5,888
| -68% | -$740K |
2020 Q4
21 quarters
|
|
|
YHC
12186
LQR House Inc
YHC
$1.67M
| $72.2K | ﹤0.01% |
+740
| New | +$67.4K |
2026 Q1
0 quarters
|
|
|
BNC
12187
CALL
BNB Standard Corporation Common Stock
BNC
$241M
| $72.1K | ﹤0.01% |
24,700
-46,300
| -65% | -$204K |
2025 Q3
2 quarters
|
|
12188
CALL
Atomera
ATOM
$184M
| $72K | ﹤0.01% |
+18,900
| New | +$71.2K |
2026 Q1
0 quarters
|
|
|
CRF
12189
Cornerstone Total Return Fund
CRF
$1.04B
| $72K | ﹤0.01% |
+10,360
| New | +$77.9K |
2026 Q1
0 quarters
|
|
|
BTLN
12190
CALL
Brightline Interactive
BTLN
$14.1M
| $71.8K | ﹤0.01% |
17,388
+11,838
| +213% | +$74.3K |
2025 Q3
2 quarters
|
|
|
ATHE
12191
Alterity Therapeutics
ATHE
$62.8M
| $71.5K | ﹤0.01% |
20,077
+3,266
| +19% | +$11.1K |
2025 Q3
2 quarters
|
|
|
BMM
12192
Blue Moon Metals Inc
BMM
$517M
| $71.3K | ﹤0.01% |
+10,908
| New | +$53K |
2026 Q1
0 quarters
|
|
|
REED
12193
Reed's Inc
REED
$8.25M
| $71.2K | ﹤0.01% |
+19,605
| New | +$53K |
2026 Q1
0 quarters
|
|
12194
PUT
Pacific Biosciences
PACB
$790M
| $71.1K | ﹤0.01% |
53,900
-95,300
| -64% | -$170K |
2020 Q1
24 quarters
|
|
12195
PUT
Cardlytics
CDLX
$14.9M
| $71.1K | ﹤0.01% |
6,770
-8,480
| -56% | -$82.7K |
2019 Q4
25 quarters
|
|
12196
CALL
Cibus
CBUS
$131M
| $71.1K | ﹤0.01% |
+35,900
| New | +$92.5K |
2026 Q1
0 quarters
|
|
12197
Indaptus Therapeutics
INDP
$317M
| $71K | ﹤0.01% |
+39,018
| New | +$83.7K |
2026 Q1
0 quarters
|
|
12198
CALL
Blink Charging
BLNK
$81.3M
| $70.9K | ﹤0.01% |
125,000
-52,400
| -30% | -$36.9K |
2020 Q1
24 quarters
|
|
|
TEAD
12199
CALL
Teads Holding Co
TEAD
$54.8M
| $70.8K | ﹤0.01% |
107,500
+78,800
| +275% | +$55.9K |
2025 Q4
1 quarter
|
|
12200
AdvisorShares Pure Cannabis ETF
YOLO
$33.2M
| $70.7K | ﹤0.01% |
+26,886
| New | +$80K |
2026 Q1
0 quarters
|
|
Similar funds
Citadel Advisors's Q1 2026 Portfolio in Review
As of Q1 2026, Citadel Advisors held 14,860 positions worth $618B, down 7.1% from $666B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Citadel Advisors's Q1 2026 filing shows 2,347 new, 5,138 increased, 5,286 reduced and 2,003 closed positions. Its largest new stake was iShares 7-10 Year Treasury Bond ETF: 3,431,225 shares worth $327M. The largest sale was Amazon, an estimated $1.33B.
By sector, the portfolio is most concentrated in Miscellaneous at 79% of assets, down from 80% a quarter earlier, followed by Technology and Healthcare.
- Citadel Advisors's largest Q1 2026 buy was iShares 7-10 Year Treasury Bond ETF: 3,431,225 shares worth $327M.
- Citadel Advisors added most to iShares Core S&P 500 ETF in Q1 2026, an estimated $2.72B increase.
- Citadel Advisors's biggest Q1 2026 reduction was Amazon, cutting an estimated $1.33B.
- Citadel Advisors fully exited CyberArk in Q1 2026, selling an estimated $305M.
- Citadel Advisors's ten largest holdings make up 22% of its $618B portfolio in Q1 2026.
- Citadel Advisors opened 2,347 new positions and closed 2,003 in Q1 2026.
- Citadel Advisors's portfolio value fell 7.1% quarter-over-quarter to $618B.
Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.